Molecular alterations in uterine PEComas frequently involve dysregulation of the mTOR signaling pathway, most often due to inactivating mutations in the TSC1 or TSC2 genes. Here, TSC2 is linked to neoplasm with perivascular epithelioid cell differentiation.